C62.92
Malignant neoplasm of left testis, unspecified whether descended or undescended
Clinical Classification Guidelines
Medical Intelligence & Overview
Malignant neoplasm of the left testis, classified under ICD-10 code C62.92, refers to a type of testicular cancer occurring specifically in the left testicle. This diagnosis involves the presence of cancerous cells that have developed in the testicular tissue and have the potential to spread to other parts of the body. The term 'unspecified whether descended or undescended' indicates that the medical record does not specify whether the testicle was in its normal position or undescended at the time of diagnosis. Testicular cancer is most common among young and middle-aged men and is considered highly treatable when diagnosed early.
Causes & Symptoms
Clinical Causes: Genetic factors, including family history of testicular cancer Presence of undescended testicle (cryptorchidism) during infancy Personal history of testicular cancer on the opposite side Certain genetic conditions or syndromes Environmental exposures, although evidence is limited
Key Symptoms: Lump or swelling in the testicle, often painless Feeling of heavy or aching in the groin or scrotum Pain or discomfort in the testicle or scrotum A sudden collection of fluid in the scrotum Back pain or swelling if the cancer has spread to lymph nodes or other organs Feeling of discomfort or unexplained weight loss in advanced cases
Diagnostic & Treatment
Diagnosis Path: Diagnosing testicular cancer typically involves a combination of clinical evaluation and diagnostic tests, including: - Physical Examination: Checking for lumps, swelling, or abnormal findings in the testicles and groin. - Ultrasound Imaging: High-frequency sound waves used to examine the testicles and identify tumors. - Blood Tests: Measuring levels of tumor markers such as alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG), and lactate dehydrogenase (LDH). - Biopsy or Surgical Removal: Often, a radical inguinal orchiectomy (removal of the testicle) is performed to confirm the diagnosis through histopathological analysis. - Imaging Studies: CT scans, X-rays, or MRI may be used to determine if the cancer has spread to other parts of the body.
Treatment Protocols: Treatment options depend on the stage and spread of the cancer and typically include: - Surgery: Removal of the affected testicle (orchiectomy) is the primary treatment. - Radiation Therapy: Uses high-energy rays to target cancer cells, mainly used for certain types of testicular cancer. - Chemotherapy: The use of anti-cancer drugs to eliminate cancer cells, especially in cases where the cancer has spread. - Surveillance: Regular follow-up monitoring without immediate additional treatment, suitable for early-stage cancers. - Additional therapies may include targeted therapy or participation in clinical trials, based on case specifics.
Clinical Advice & FAQs
Billing Guidance
Is C62.92 a billable ICD-10 code?
Yes, C62.92 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C62.92?
Clinical documentation must specify the nature of Malignant neoplasm of left testis, unspecified whether descended or undescended and any associated comorbidities for accurate reporting.
Cite this Clinical Reference